C07F 9 - Compounds containing elements of the 5th group of the periodic system

Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2004
12/22/2004	CN1181082C Method for producing triethyl phosphate with high purity
12/22/2004	CN1181056C 4-acylamino piperidin-N-oxides
12/22/2004	CN1180689C Process for making ammonium glyphosate powder
12/21/2004	US6833480 Useful in inhibiting proliferation of and/or killing cancer cells
12/21/2004	US6833467 Ball milling a mixture including P2O5, pentaerythritol, an alkyl benzene and a metal halide catalyst, in a ball mill reactor at a temperature of 70-150 degrees C
12/21/2004	US6833457 Process for preparation of benzylpiperidine compounds
12/21/2004	US6833442 Complex and method for producing epoxides by using the complex
12/21/2004	CA2346408C Hydroformylation process using chlorophosphite-metal catalyst system
12/16/2004	WO2004108737A1 Process for producing phosphonitrilic acid ester
12/16/2004	WO2004108736A1 Organophosphorus compound having phosphate-phosphonate bond, and flame-retardant polyester fiber and flame-retardant polyurethane resin composition each containing the same
12/16/2004	WO2004108735A2 Polymer compositions containing stabilizer compounds comprising tricyclodecilmethyl groups
12/16/2004	WO2004108669A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
12/16/2004	WO2004076464A3 Optically active phosphites and phosphoramidites and their use in asymmetric reactions
12/16/2004	WO2004052939A3 Ligands for metals and improved metal-catalyzed processes based thereon
12/16/2004	US20040254390 Reacting naphthol with phosphorus oxychloride in the presence of a metallic halide and removing unreacted phosphorus oxychloride and reacting the reaction product with phenol and removing hydrogen chloride produced as a by-product; fire retardants
12/16/2004	US20040254218 Substituted piperidine compounds and methods of their use
12/16/2004	US20040254182 Enhanced propertied pharmaceuticals
12/16/2004	US20040254149 Antiproliferative agents; antiinflammatory agents; anticancer agents; diagnosis, therapy
12/16/2004	US20040254141 Therapy for hepatitis B virus infection ; antiproliferative agents; antitumor agents; anticancer agents
12/16/2004	US20040254119 Polypeptide conjugates with extended circulating half-lives
12/16/2004	US20040254103 Water-soluble shps as novel alkylating agents
12/16/2004	DE10323276A1 Transition metal complex for olefin polymerization catalyst system, consists of Group 3-6 transition metal and specific tridentate nitrogen-containing ligand
12/16/2004	CA2528006A1 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
12/15/2004	EP1486490A1 Azole compounds
12/15/2004	EP1485395A2 Nucleotide mimics and their prodrugs
12/15/2004	EP1485392A2 Bisphosphite ligands for carbonylation processes
12/15/2004	EP1485391A2 Phosphate transport inhibitors
12/15/2004	EP1485107A1 Phospholipids as caspase inhibitor prodrugs
12/15/2004	EP1485085A1 Phosphate prodrugs of fluorooxindoles
12/15/2004	EP1485082A1 Methods for synthesis of prodrugs from 1-acyl-alkyl derivatives and compositions thereof
12/15/2004	EP1401846B1 Method for producing n-phosphonomethylglycine
12/15/2004	EP1117639B1 Benzoylcyclohexandiones, method for the production and use thereof as herbicides and plant growth regulators
12/15/2004	CN1554350A Nucleotide analog composition and synthesis method
12/15/2004	CN1179967C Preparation method of high purity soyabean lecithin
12/15/2004	CN1179966C Method for preparing artificial hapten, artificial antigen and specific antibody of chlorpyrifos and its usage
12/15/2004	CN1179965C Phosphate type liquid alicyclic olefin compound and its preparation method
12/14/2004	US6831160 Method of affinity purifying proteins using modified bis-arsenical fluorescein
12/14/2004	US6831105 For therapy and prophylaxis of cardiovascular diseases, dyslipidemias, dysproteinemias, and glucose metabolism disorders
12/14/2004	US6831096 Effective against both A and B forms of influenza; oral bioavailability
12/14/2004	CA2225453C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy and diagnosis
12/14/2004	CA2180867C Monomeric diols and phosphate linked oligomers formed therefrom
12/09/2004	WO2004106486A2 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
12/09/2004	WO2004106350A1 Nucleoside analogs as viral polymerase inhibitors
12/09/2004	WO2004106349A1 Fuel cell membrane containing zirconium phosphate
12/09/2004	WO2004106328A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/09/2004	WO2004106288A2 Ionic liquids containing guanidinium cations
12/09/2004	WO2004106287A1 Ionic liquid comprising uronium cations or thiouronium cations
12/09/2004	WO2004106280A1 CaSR ANTAGONIST
12/09/2004	WO2004105773A2 Use of s1p
12/09/2004	WO2004105764A1 (3- ((quinazolin-4-yl) amino )-1h-pyrazol-1-yl) acetamide derivatives and related compounds as aurora kinase inhibitors for the treatment of proliferative diseases such as cancer
12/09/2004	WO2004105700A2 Compounds, methods and pharmaceutical compositions for inhibiting parp
12/09/2004	WO2004105697A2 Novel lipids for transfection of nucleic acids
12/09/2004	WO2004078144A3 Diphenylethylene compounds and uses thereof
12/09/2004	WO2004062595A3 Antineoplastic ether lipid compounds with modifications at the sn-1 carbon
12/09/2004	WO2004062594A3 Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
12/09/2004	WO2004062593A3 Antineoplastic ether lipid compounds with modifications at the sn-2 carbon
12/09/2004	WO2004062586A3 Antineoplastic ether lipid compounds
12/09/2004	US20040249216 a multidentate organic phosphorous ligand for preparing alkenecarboxylic acid derivatives by carbonylation of conjugated dienes in the presence of a hydroxyl-containing compound in the liquid phase in the presence of a carbonylation catalyst that comprises a palladium compound
12/09/2004	US20040249195 Lithium rho-diarylphosphinobenzenesulfonates, process for preparation of the same and use thereof
12/09/2004	US20040249194 comprises hydrolysis of vinylphosphonic acid ester in presence of carbonyl compound; acid catalysts
12/09/2004	US20040249184 aromatic fused phosphepine ligands, e.g., 4-Phenyl-4,5-dihydro-3H-dinaphtho[2,1-c; 1',2'-e]phosphepine and their preparation from 2,2'-dimethylbiphenyls or binaphthyls and aminophosphorus dichlorides or aryl or alkyl phosphorus dichlorides; hydrogenation catalysts with metal compounds
12/09/2004	US20040249172 Process for the preparationof prostaglandins and analogues thereof
12/09/2004	US20040249030 Polymer compositions containing stabilizer compounds comprising tricyclodecylmethyl groups
12/09/2004	US20040249028 Phosphorus-containing carboxylic acid derivatives process for preparations thereof and flame retardant
12/09/2004	US20040248952 Novel bicyclic compounds and compositions
12/09/2004	US20040248855 Process for the preparation of acylphosphines, acyl oxides and acyl sulfides
12/09/2004	US20040248852 Chemical compounds
12/09/2004	US20040247621 Combination therapy using a synergistic mixture of mechlorethamine, nitrogen mustard N-oxide, melphalan, uramustin, ifosfamide, chlorambucil, or cyclophosphamide and an anti-interleukin-6 receptor antibody; anticarcinogenic agents
12/09/2004	US20040245504 Triboluminescent materials and devices
12/09/2004	DE10323692A1 Chirale Liganden und deren Übergangsmetallkomplexe Chiral ligands and their transition metal complexes
12/09/2004	CA2809131A1 Use of s1p
12/09/2004	CA2527785A1 Ionic liquid comprising uronium cations or thiouronium cations
12/09/2004	CA2527759A1 Use of s1p
12/09/2004	CA2527583A1 Triheterocyclic compounds, compositions, and methods for treating cancer or viral diseases
12/09/2004	CA2527483A1 Oxidized lipids and uses thereof in the treatment of inflammatory diseases and disorders
12/09/2004	CA2527420A1 Compounds, methods and pharmaceutical compositions for inhibiting parp
12/08/2004	EP1484334A2 Process for producing phosphite
12/08/2004	EP1484333A1 New aminopropylphosphonous acids
12/08/2004	EP1484313A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
12/08/2004	EP1484061A1 Drugs containing riboflavin-type compounds
12/08/2004	EP1483276A1 Ferrocenyl ligands and the use thereof in catalysis
12/08/2004	EP1483274A1 Improved method for the production of biphosphites
12/08/2004	EP1483273A2 Ligands for asymmetric reactions
12/08/2004	EP1483254A1 Resistance-repellent retroviral protease inhibitors
12/08/2004	EP1482954A2 Alpha-substituted arylalkyl phosphonate derivatives
12/08/2004	EP1482953A1 Alpha-substituted heteroarylalkyl phosphonate derivattives
12/08/2004	EP1482897A2 Aminodiphosphonate apolipoprotein e modulators
12/08/2004	EP1482896A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1482895A2 Aminoalkylphosphonates and related compounds as edg receptor agonists
12/08/2004	EP1240152B1 Ox(adi)azolyl-hydroxamic acids useful as procollagen c-proteinase inhibitors
12/08/2004	EP0970239B1 Detection of microbial metabolites
12/08/2004	CN1552719A Catalystic preparation of nitrine diphenyl posphate
12/08/2004	CN1178947C Method for producing phosphonium phenolates
12/08/2004	CN1178946C Vanadium compound and its preparing process and usage
12/08/2004	CN1178867C Neutral scavenger for running water circulating system
12/08/2004	CN1178665C Water soluble prodrugs of azole compounds
12/07/2004	US6828453 Phospholipid-analogous compounds
12/07/2004	US6828442 Preparation of n-protected-3-pyrrolidine-lactam substituted phosphonium salts
12/07/2004	US6828439 Compounds, composition, and methods for photodynamic therapy
12/07/2004	US6828427 Oligomeric aminodiol-containing compounds, libraries thereof, and process of preparing the same

1 ... 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 ... 554